
Coronavirus News Roundup: Johnson and Johnson Resumes Vaccine in Europe, Rapid Antigen Test Now Available for OTC Purchase
Here’s a roundup of the latest coronavirus-related news.
This week, President Biden opened COVID-19 vaccination to all Americans over the age of 16 years. While more Americans are gearing up to get their shots, Johnson & Johnson’s vaccine resumed distribution in Europe after a safety pause, and rapid antigen COVID-19 tests have been made available for OTC purchase in some pharmacies.
Here’s a roundup of the latest coronavirus-related news.
The European Medicines Agency determined that the benefits of Johnson & Johnson’s COVID-19 vaccine outweigh the risks. The vaccine is still paused in the United States.
Beginning this week, the OTC self-administered rapid antigen test will be available in Walgreens stores for $23.99.
COVID-19 may be mild in most cases for children, but severe cases do happen. An investigation offers insight into what factors may contribute to those cases.
Six patients among 491 with autoimmune inflammatory rheumatic diseases (AIIRD) developed shingles after being vaccinated with the Pfizer vaccine compared to none among 99 controls, researchers reported.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.

























































































































































